EdgarLookup

CBIZ, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that CBIZ, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
58%
Profit Margin
Net income ÷ revenue
2.6%
Return on Assets
Net income ÷ assets
1.5x
Debt-to-Equity
Total liabilities ÷ equity
-11.2%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2018 Dec 31, 2018 $199.02M Feb 28, 2019
FY2018 Sep 30, 2018 $224.25M Feb 28, 2019
FY2018 Jun 30, 2018 $232.64M Feb 28, 2019
FY2018 Mar 31, 2018 $266.09M Feb 28, 2019
FY2018 Dec 31, 2017 $195.14M Feb 28, 2019
FY2018 Sep 30, 2017 $207.72M Feb 28, 2019
FY2018 Jun 30, 2017 $211.02M Feb 28, 2019
FY2018 Mar 31, 2017 $241.46M Feb 28, 2019
FY2017 Dec 31, 2016 $178.79M Mar 1, 2018
FY2017 Sep 30, 2016 $199.79M Mar 1, 2018

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.76B Feb 26, 2026
FY2025 Dec 31, 2024 $1.81B Feb 26, 2026
FY2025 Dec 31, 2023 $1.59B Feb 26, 2026
FY2024 Dec 31, 2022 $1.41B Feb 28, 2025
FY2023 Dec 31, 2021 $1.10B Feb 23, 2024
FY2020 Dec 31, 2020 $211.11M Feb 26, 2021
FY2020 Sep 30, 2020 $238.39M Feb 26, 2021
FY2020 Jun 30, 2020 $236.94M Feb 26, 2021
FY2020 Mar 31, 2020 $277.46M Feb 26, 2021
FY2020 Dec 31, 2019 $203.14M Feb 26, 2021

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $355.39M Feb 26, 2026
FY2025 Dec 31, 2024 $182.47M Feb 26, 2026
FY2025 Dec 31, 2023 $223.20M Feb 26, 2026
FY2024 Dec 31, 2022 $223.37M Feb 28, 2025
FY2023 Dec 31, 2021 $159.29M Feb 23, 2024
FY2020 Dec 31, 2020 ($638.0K) Feb 26, 2021
FY2020 Sep 30, 2020 $33.63M Feb 26, 2021
FY2020 Jun 30, 2020 $27.93M Feb 26, 2021
FY2020 Mar 31, 2020 $77.63M Feb 26, 2021
FY2020 Dec 31, 2019 $2.43M Feb 26, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $115.44M Feb 26, 2026
FY2025 Dec 31, 2024 $41.04M Feb 26, 2026
FY2025 Dec 31, 2023 $120.97M Feb 26, 2026
FY2024 Dec 31, 2022 $105.35M Feb 28, 2025
FY2023 Dec 31, 2021 $70.89M Feb 23, 2024
FY2020 Dec 31, 2020 ($94.0K) Feb 26, 2021
FY2020 Sep 30, 2020 $20.08M Feb 26, 2021
FY2020 Jun 30, 2020 $21.47M Feb 26, 2021
FY2020 Mar 31, 2020 $36.85M Feb 26, 2021
FY2020 Dec 31, 2019 ($1.15M) Feb 26, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $234.01M Feb 26, 2026
FY2025 Dec 31, 2024 $73.72M Feb 26, 2026
FY2025 Dec 31, 2023 $165.24M Feb 26, 2026
FY2024 Dec 31, 2022 $168.34M Feb 28, 2025
FY2023 Dec 31, 2021 $72.67M Feb 23, 2024
FY2020 Dec 31, 2020 ($13.72M) Feb 26, 2021
FY2020 Sep 30, 2020 $22.29M Feb 26, 2021
FY2020 Jun 30, 2020 $16.77M Feb 26, 2021
FY2020 Mar 31, 2020 $67.14M Feb 26, 2021
FY2020 Dec 31, 2019 ($8.06M) Feb 26, 2021

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $192.49M Feb 26, 2026
FY2025 Dec 31, 2024 $123.69M Feb 26, 2026
FY2025 Dec 31, 2023 $153.51M Feb 26, 2026
FY2024 Dec 31, 2022 $126.13M Feb 28, 2025
FY2023 Dec 31, 2021 $131.15M Feb 23, 2024
FY2022 Dec 31, 2020 $146.85M Feb 24, 2023
FY2021 Dec 31, 2019 $98.19M Feb 25, 2022
FY2020 Dec 31, 2018 $105.25M Feb 26, 2021
FY2019 Dec 31, 2017 $77.04M Feb 26, 2020
FY2018 Dec 31, 2016 $74.06M Feb 28, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $16.96M Feb 26, 2026
FY2025 Dec 31, 2024 $12.91M Feb 26, 2026
FY2025 Dec 31, 2023 $23.05M Feb 26, 2026
FY2024 Dec 31, 2022 $8.64M Feb 28, 2025
FY2023 Dec 31, 2021 $8.98M Feb 23, 2024
FY2022 Dec 31, 2020 $11.58M Feb 24, 2023
FY2021 Dec 31, 2019 $13.87M Feb 25, 2022
FY2020 Dec 31, 2018 $14.62M Feb 26, 2021
FY2019 Dec 31, 2017 $11.89M Feb 26, 2020
FY2018 Dec 31, 2016 $4.14M Feb 28, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.41B Feb 26, 2026
FY2025 Dec 31, 2024 $4.47B Feb 26, 2026
FY2024 Dec 31, 2023 $2.04B Feb 28, 2025
FY2023 Dec 31, 2022 $1.88B Feb 23, 2024
FY2022 Dec 31, 2021 $1.63B Feb 24, 2023
FY2021 Dec 31, 2020 $1.51B Feb 25, 2022
FY2020 Dec 31, 2019 $1.40B Feb 26, 2021
FY2019 Dec 31, 2018 $1.18B Feb 26, 2020
FY2018 Dec 31, 2017 $1.18B Feb 28, 2019
FY2017 Dec 31, 2016 $1.12B Mar 1, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.65B Feb 26, 2026
FY2025 Dec 31, 2024 $2.69B Feb 26, 2026
FY2024 Dec 31, 2023 $1.25B Feb 28, 2025
FY2023 Dec 31, 2022 $1.17B Feb 23, 2024
FY2022 Dec 31, 2021 $923.39M Feb 24, 2023
FY2021 Dec 31, 2020 $811.13M Feb 25, 2022
FY2020 Dec 31, 2019 $741.54M Feb 26, 2021
FY2019 Dec 31, 2018 $589.37M Feb 26, 2020
FY2018 Dec 31, 2017 $645.35M Feb 28, 2019
FY2017 Dec 31, 2016 $638.57M Mar 1, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.76B Feb 26, 2026
FY2025 Dec 31, 2024 $1.78B Feb 26, 2026
FY2025 Dec 31, 2023 $791.62M Feb 26, 2026
FY2025 Dec 31, 2022 $713.45M Feb 26, 2026
FY2024 Dec 31, 2021 $704.55M Feb 28, 2025
FY2023 Dec 31, 2020 $702.62M Feb 23, 2024
FY2022 Dec 31, 2019 $659.24M Feb 24, 2023
FY2021 Dec 31, 2018 $593.66M Feb 25, 2022
FY2020 Dec 31, 2017 $530.88M Feb 26, 2021
FY2019 Dec 31, 2016 $480.02M Feb 26, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.33B Feb 26, 2026
FY2025 Dec 31, 2024 $2.33B Feb 26, 2026
FY2025 Dec 31, 2023 $865.18M Feb 26, 2026
FY2024 Dec 31, 2022 $819.92M Feb 28, 2025
FY2023 Dec 31, 2021 $740.74M Feb 23, 2024
FY2022 Dec 31, 2020 $683.08M Feb 24, 2023
FY2021 Dec 31, 2019 $588.21M Feb 25, 2022
FY2020 Dec 31, 2018 $564.30M Feb 26, 2021
FY2019 Dec 31, 2017 $528.42M Feb 26, 2020
FY2018 Dec 31, 2016 $487.48M Feb 28, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.01B Feb 26, 2026
FY2025 Dec 31, 2024 $896.12M Feb 26, 2026
FY2024 Dec 31, 2023 $855.08M Feb 28, 2025
FY2023 Dec 31, 2022 $734.12M Feb 23, 2024
FY2022 Dec 31, 2021 $628.76M Feb 24, 2023
FY2021 Dec 31, 2020 $557.88M Feb 25, 2022
FY2020 Dec 31, 2019 $479.58M Feb 26, 2021
FY2019 Dec 31, 2018 $408.96M Feb 26, 2020
FY2018 Dec 31, 2017 $345.30M Feb 28, 2019
FY2017 Dec 31, 2016 $294.93M Mar 1, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $18.29M Feb 26, 2026
FY2025 Dec 31, 2024 $13.83M Feb 26, 2026
FY2025 Dec 31, 2023 $8.09M Feb 26, 2026
FY2024 Dec 31, 2022 $4.70M Feb 28, 2025
FY2023 Dec 31, 2021 $2.00M Feb 23, 2024
FY2022 Dec 31, 2020 $4.65M Feb 24, 2023
FY2021 Dec 31, 2019 $567.0K Feb 25, 2022
FY2020 Dec 31, 2018 $640.0K Feb 26, 2021
FY2019 Dec 31, 2017 $424.0K Feb 26, 2020
FY2018 Dec 31, 2016 $3.49M Feb 28, 2019

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 26, 2026
FY2025 Dec 31, 2024 0 Feb 26, 2026
FY2025 Dec 31, 2023 2 Feb 26, 2026
FY2024 Dec 31, 2022 2 Feb 28, 2025
FY2023 Dec 31, 2021 1 Feb 23, 2024
FY2020 Dec 31, 2020 0 Feb 26, 2021
FY2020 Sep 30, 2020 0 Feb 26, 2021
FY2020 Jun 30, 2020 0 Feb 26, 2021
FY2020 Mar 31, 2020 0 Feb 26, 2021
FY2020 Dec 31, 2019 0 Feb 26, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 26, 2026
FY2025 Dec 31, 2024 0 Feb 26, 2026
FY2025 Dec 31, 2023 2 Feb 26, 2026
FY2024 Dec 31, 2022 2 Feb 28, 2025
FY2023 Dec 31, 2021 1 Feb 23, 2024
FY2020 Dec 31, 2020 0 Feb 26, 2021
FY2020 Sep 30, 2020 0 Feb 26, 2021
FY2020 Jun 30, 2020 0 Feb 26, 2021
FY2020 Mar 31, 2020 0 Feb 26, 2021
FY2020 Dec 31, 2019 0 Feb 26, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 54.38M Feb 26, 2026
FY2025 Dec 31, 2024 50.20M Feb 26, 2026
FY2024 Dec 31, 2023 49.81M Feb 28, 2025
FY2023 Dec 31, 2022 50.18M Feb 23, 2024
FY2022 Dec 31, 2021 52.04M Feb 24, 2023
FY2021 Dec 31, 2020 54.10M Feb 25, 2022
FY2020 Dec 31, 2019 55.42M Feb 26, 2021
FY2019 Dec 31, 2018 55.07M Feb 26, 2020
FY2018 Dec 31, 2017 54.59M Feb 28, 2019
FY2017 Dec 31, 2016 54.04M Mar 1, 2018